Clinical Trials Browser

Phase 1 × Myelodysplastic Syndromes × Atorvastatin × Clear all

NCT03560882 2024-03-21

A Pilot Trial of Atorvastatin in Tumor Protein 53 (p53) -Mutant and p53 Wild-Type Malignancies

Phase 1 Active not recruiting

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Neoplasms, Leukemia, Myeloid, Acute, Hematologic Neoplasms